The use of oral midazolam for perioperative anxiolysis of healthy patients undergoing Mohs surgery: Conclusions from randomized controlled and prospective studies
“…Before and during dermatologic surgery, patients’ anxiety may be reduced through the use of relaxation strategies such as hypnotic induction, self-guided imagery, 19 and listening to music 4 or by premedication with amnestic benzodiazepines such as midazolam 16 and alprazolam. 6 In patients with needle phobia, needle-free anesthesia may be used to make the required surgical procedures possible.…”
“…Before and during dermatologic surgery, patients’ anxiety may be reduced through the use of relaxation strategies such as hypnotic induction, self-guided imagery, 19 and listening to music 4 or by premedication with amnestic benzodiazepines such as midazolam 16 and alprazolam. 6 In patients with needle phobia, needle-free anesthesia may be used to make the required surgical procedures possible.…”
“…Anxiety levels may be heightened in patients undergoing MMS due to the inherent uncertainties of tumour removal in between layers, coupled with the variable time period patients physically have to stay until wound closure. A variety of methods have been reported in minimizing patient anxiety during MMS including personalized music 3 and the use of oral midazolam perioperatively 4 …”
“…12 For those most anxious before injection, administering a fastacting benzodiazepine orally (midazolam, alprazolam, or diazepam) can considerably reduce the fear of injection. 17 The potential retrograde amnestic effect is an added benefit that may reduce any perceived trauma from the experience.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.